Julian Knoerlein

Julian Knoerlein

Auto-generated profile, based on publicly available information

Julian Knoerlein

Department of Anaesthesiology and Critical Care, Medical Center-University, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WBWolfgang Baar
Wolfgang Baar
ASAxel Semmelmann
Axel Semmelmann
JKJulian Knoerlein
Julian Knoerlein
FWFrederike Weber
Frederike Weber
SHSebastian Heinrich
Sebastian Heinrich
TLTorsten Loop
Torsten Loop
Postoperative pulmonary complications (PPCs) represent the most frequent complications after lung surgery, and they increase postoperative mortality. This study investigated the incidence of PPCs, in-hospital mortality rate, and risk factors leading to PPCs in patients undergoing open thoracotomy lung resections (OTLRs) for primary lung cancer. The data from 1426 patients in this multicentre retrospective study were extracted from the German Thorax Registry and presented after univariate and multivariate statistical processing. A total of 472 patients showed at least one PPC. The presence of two PPCs was associated with a significantly increased mortality rate of 7% (p < 0.001) compared to that of patients without or with a single PPC. Three or more PPCs increased the mortality rate to 33% (p < 0.001). Multivariate stepwise logistic regression analysis revealed male gender (OR 1.4), age > 60 years (OR 1.8), and current or previous smoking (OR 1.6), while the pre-operative risk factors were still CRP levels > 3 mg/dl (OR 1.7) and FEV1 < 60% (OR 1.4). Procedural independent risk factors for PPCs were: duration of surgery exceeding 195 min (OR 1.6), the amount of intraoperative blood loss (OR 1.6), partial ligation of the pulmonary artery (OR 1.5), continuing invasive ventilation after surgery (OR 2.9), and infusion of intraoperative crystalloids exceeding 6 mL/kg/h (OR 1.9). The incidence of PPCs was significantly lower in patients with continuous epidural or paravertebral analgesia (OR 0.7). Optimising perioperative management by implementing continuous neuroaxial techniques and optimised fluid therapy may reduce the incidence of PPCs and associated mortality.

5 May 2021 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
JKJohannes Kalbhenn
Johannes Kalbhenn
JKJulian Knörlein
Julian Knörlein
MPMatthias Jakob Posch
Matthias Jakob Posch

27 January 2023 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
PDF file
JKJulian Knoerlein
Julian Knoerlein
PBPhilipp Brodbeck
Philipp Brodbeck
MBMartin Büchsel
Martin Büchsel
BZBarbara Zieger
Barbara Zieger
ASAxel Schmutz
Axel Schmutz
Objective To determine the incidence of increased anti-Xa activity within plasma levels 24 hours after administration of therapeutic dose low-molecular-weight heparin in patients presenting for elective neuraxial anesthesia. Background Guidelines for neuroaxial regional anesthesia for patients with antithrombotic drugs recommend time intervals for waiting. There is scientific evidence to suggest that the recommended interval of 24 hours may be insufficient in patients treated with therapeutic dose low-molecular-weight heparin. Methods Retrospective cohort analysis of 74 patients who received therapeutic dose low-molecular-weight heparin before planned neuraxial anesthesia between April 1, 2015 and April 1, 2020 at Freiburg University Hospital. Primary endpoint was the occurrence of elevated plasma anti-Xa levels in prophylactic range or higher (>0.2 IU/mL) 24 hours after the last application of the therapeutic dose. Results 24 hours after the last dose of therapeutic low-molecular-weight heparin, 18.0% of patients had elevated anti-Xa activity levels >0.2 IU/mL. A weak correlation between the time since the last administration of low-molecular-weight heparin and plasma anti-Xa levels could be found. No other risk factors were seen. Conclusions Relevant residual anticoagulant activity, as measured by plasma anti-Xa levels within a prophylactic range, is measurable 24 hours after the last administration of therapeutic dose low-molecular-weight heparin. Trial registration number German Clinical Trials Register DRKS00022099.

15 November 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
RPRaphael Porsche
Raphael Porsche
FSFrederic Steinhardt
Frederic Steinhardt
JKJulian Knoerlein
Julian Knoerlein
MSMartin Schick
Martin Schick
Objective The main objective of this study was to assess the impact of phenylephrine and cafedrine/theodrenaline on the mother and newborn after spinal anaesthesia for caesarean section. Setting University teaching hospital. Design A single-centre retrospective data cohort study. Patients All obstetric patients who were scheduled for caesarean section in a 2-year period. Interventions Administration of either intravenous phenylephrine prophylactically or cafedrine/theodrenaline (Akrinor) reactively to maintain blood pressure after spinal anaesthesia. Main outcome measure Maternal hypotension, heart rate during caesarean section and after admission to IMC, fetal arterial cord pH and base excess levels, maternal volume resuscitation and the use of rescue medication. Results 852 data sets could be included: n=440 Akrinor, n=412 in the phenylephrine cohort. During caesarean section blood pressure was slightly higher in the phenylephrine group compared with the Akrinor group, while hypotension <100 mm Hg systolic blood pressure (SBP) occurred significantly more often during arrival at the IMC after surgery when phenylephrine was used. Heart rate was lower and rescue medication was significantly more frequently given in the phenylephrine cohort. Irrespective of the medication used, women with baseline levels of <120 mm Hg SBP had a high risk to develop hypotension <100 mm Hg after spinal anaesthesia for caesarean section. While there was no statistical difference in mean umbilical arterial pH levels, the incidence of acidosis, defined as pH <7.2, was significantly higher with phenylephrine. Conclusion Phenylephrine was not superior to Akrinor to treat spinal anaesthesia-induced maternal hypotension during caesarean section. Trial registration number DRKS00025795.

10 November 2021 in Journal of Clinical Urology
Verified
Journal Article
Closed access
PDF file
JKJulian Knoerlein
Julian Knoerlein
SHSebastian Heinrich
Sebastian Heinrich
KKKai Kaufmann
Kai Kaufmann
WSWolfgang Schultze-Seemann
Wolfgang Schultze-Seemann
WBWolfgang Baar
Wolfgang Baar
JKJohannes Kalbhenn
Johannes Kalbhenn
Objective: To compare the effect of combined epidural thoracic analgesia and general anaesthesia (CEGA) in radical cystectomy (RC) with respect to the return of gastrointestinal passage, the incidence of paralytic postoperative ileus (POI) compared to general anaesthesia (GA) only. Patients and methods: We conducted a retrospective review using the electronic medical records of 236 patients who underwent RCs between July 2011 and September 2018 at the Medical Center – University of Freiburg. Results: A CEGA was administered to 202 patients, while 34 patients received only GA. The baseline characteristics of patients with and without CEGA showed no significant differences. CEGA will decrease the time required for return of gastrointestinal transit as measured by time to first defecation by about 13 hours. In the first 90 days after surgery, 82 (34.7%) patients had a POI. There was no significant difference between complications in the CEGA and GA groups. Conclusion: A CEGA accelerates the return of the gastrointestinal transit but does not reduce the incidence of postoperative ileus. Level of evidence: 2b